These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24836200)

  • 1. Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster.
    Gulick D; Chau DT; Khokhar JY; Dawson R; Green AI
    Psychiatry Res; 2014 Aug; 218(3):329-34. PubMed ID: 24836200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan.
    Khokhar JY; Chau DT; Dawson R; Green AI
    Drug Alcohol Depend; 2015 Jul; 152():277-81. PubMed ID: 25979645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desipramine enhances the ability of paliperidone to decrease alcohol drinking.
    Chau DT; Khokhar JY; Gulick D; Dawson R; Green AI
    J Psychiatr Res; 2015 Oct; 69():9-18. PubMed ID: 26343589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of iloperidone, combined with desipramine, on alcohol drinking in the Syrian golden hamster.
    Khokhar JY; Green AI
    Neuropharmacology; 2016 Jun; 105():25-34. PubMed ID: 26796639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raclopride lessens the ability of clozapine to suppress alcohol drinking in Syrian golden hamsters.
    Chau DT; Ahmed J; Wang TT; Xie H; Dawson R; Green AI
    Neuropharmacology; 2011 Sep; 61(4):646-52. PubMed ID: 21619888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine reduces alcohol drinking in Syrian golden hamsters.
    Green AI; Chau DT; Keung WM; Dawson R; Mesholam RI; Schildkraut JJ
    Psychiatry Res; 2004 Aug; 128(1):9-20. PubMed ID: 15450910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
    Bruggeman R; Westerink BH; Timmerman W
    Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone reduces limited access alcohol drinking in alcohol-preferring rats.
    Ingman K; Honkanen A; Hyytiä P; Huttunen MO; Korpi ER
    Eur J Pharmacol; 2003 May; 468(2):121-7. PubMed ID: 12742519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
    Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine chronically suppresses alcohol drinking in Syrian golden hamsters.
    Chau DT; Gulick D; Xie H; Dawson R; Green AI
    Neuropharmacology; 2010 Feb; 58(2):351-6. PubMed ID: 19895824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo.
    Elman I; Goldstein DS; Green AI; Eisenhofer G; Folio CJ; Holmes CS; Pickar D; Breier A
    Neuropsychopharmacology; 2002 Aug; 27(2):293-300. PubMed ID: 12093603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophrenia.
    Uchida H; Rajji TK; Mulsant BH; Kapur S; Pollock BG; Graff-Guerrero A; Menon M; Mamo DC
    J Clin Psychopharmacol; 2009 Dec; 29(6):571-5. PubMed ID: 19910723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial.
    Green AI; Brunette MF; Dawson R; Buckley P; Wallace AE; Hafez H; Herz M; Narasimhan M; Noordsy DL; O'Keefe C; Sommi RW; Steinbook RM; Weeks M
    J Clin Psychiatry; 2015 Oct; 76(10):1359-65. PubMed ID: 26302441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose relationship of limbic-cortical D2-dopamine receptor occupancy with risperidone.
    Yasuno F; Suhara T; Okubo Y; Sudo Y; Inoue M; Ichimiya T; Tanada S
    Psychopharmacology (Berl); 2001 Feb; 154(1):112-4. PubMed ID: 11292000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG; Gil R; Hackett E; Mawlawi O; Zea-Ponce Y; Zhu Z; Kochan LD; Cangiano C; Slifstein M; Gorman JM; Laruelle M; Abi-Dargham A
    Psychopharmacology (Berl); 2004 Oct; 175(4):473-80. PubMed ID: 15083259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.